These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35020936)

  • 1. Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.
    Ahmed AO; Kirkpatrick B; Granholm E; Rowland LM; Barker PB; Gold JM; Buchanan RW; Outram T; Bernardo M; Paz García-Portilla M; Mane A; Fernandez-Egea E; Strauss GP
    Schizophr Bull; 2022 May; 48(3):620-630. PubMed ID: 35020936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
    Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Esfahlani FZ; Galderisi S; Mucci A; Rossi A; Bucci P; Rocca P; Maj M; Kirkpatrick B; Ruiz I; Sayama H
    Schizophr Bull; 2019 Sep; 45(5):1033-1041. PubMed ID: 30256991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
    Bègue I; Kaiser S; Kirschner M
    Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [History and current state of the problem of negative disorders (research of nosological period)].
    Smulevich AB; Lobanova VM; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):122-130. PubMed ID: 33728861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.
    Strauss GP; Bartolomeo LA; Harvey PD
    NPJ Schizophr; 2021 Feb; 7(1):16. PubMed ID: 33637748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia.
    Cheon EJ; Male AG; Gao B; Adhikari BM; Edmond JT; Hare SM; Belger A; Potkin SG; Bustillo JR; Mathalon DH; Ford JM; Lim KO; Mueller BA; Preda A; O'Leary D; Strauss GP; Ahmed AO; Thompson PM; Jahanshad N; Kochunov P; Calhoun VD; Turner JA; van Erp TGM
    Psychiatry Res Neuroimaging; 2023 Mar; 329():111597. PubMed ID: 36680843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative Symptoms and Their Associations With Other Clinical Variables and Working Memory Across the Schizophrenia Spectrum and Bipolar Disorder.
    De Pieri M; Berg X; Georgiadis F; Brakowski J; Burrer A; Sabé M; Kaliuzhna M; Vetter S; Seifritz E; Homan P; Kaiser S; Kirschner M
    Schizophr Bull Open; 2024 Jan; 5(1):sgae024. PubMed ID: 39430551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of negative symptoms on health-related quality of life in schizophrenia.
    Li Y; Rekhi G; Ang MS; Lee J
    Front Psychiatry; 2023; 14():1252354. PubMed ID: 37744001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.
    Chang WC; Strauss GP; Ahmed AO; Wong SCY; Chan JKN; Lee EHM; Chan SKW; Hui CLM; James SH; Chapman HC; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):386-394. PubMed ID: 32909606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
    Guessoum SB; Le Strat Y; Dubertret C; Mallet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.
    Ahmed AO; Kirkpatrick B; Galderisi S; Mucci A; Rossi A; Bertolino A; Rocca P; Maj M; Kaiser S; Bischof M; Hartmann-Riemer MN; Kirschner M; Schneider K; Garcia-Portilla MP; Mane A; Bernardo M; Fernandez-Egea E; Jiefeng C; Jing Y; Shuping T; Gold JM; Allen DN; Strauss GP
    Schizophr Bull; 2019 Mar; 45(2):305-314. PubMed ID: 29912473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
    Kirkpatrick B
    J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.